![Anthony Manning](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Anthony Manning
Direktor/Vorstandsmitglied bei
MONTE ROSA THERAPEUTICS, INC.
Vermögen: 10 108 $ am 31.05.2026
Profil
Derzeit ist Anthony M. Manning Vorsitzender des Institute For Biomedical Entrepreneurship, Inc. und Chief Scientific Officer von Momenta Pharmaceuticals, Inc. Dr. Manning ist außerdem Mitglied des Vorstands von Palatin Technologies, Inc. Dr. Manning war zuvor als SVP-Research & Preclinical Development bei Aileron Therapeutics, Inc. tätig, als Vice President & Head-Autoimmune Diseases Research bei Biogen, Inc. als Head-Research bei Celgene Corp. als Vice President & Global Head-Inflammation bei Roche Pharmaceuticals, Inc. als Principal bei Signal Pharmaceuticals, Inc. und als Vice President bei Pharmacia Corp. Er erhielt einen Doktortitel von der University of Otago.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 20.06.2025 | 721 ( 0.04% ) | 10 108 $ | 31.05.2026 | |
| 29.06.2026 | 0 ( -.--% ) | - $ | 31.05.2026 |
Aktive Positionen von Anthony Manning
| Unternehmen | Position | Beginn |
|---|---|---|
| MONTE ROSA THERAPEUTICS, INC. | Direktor/Vorstandsmitglied | 25.07.2023 |
Institute For Biomedical Entrepreneurship, Inc. | Gründer | - |
Ehemalige bekannte Positionen von Anthony Manning
| Unternehmen | Position | Ende |
|---|---|---|
| REIN THERAPEUTICS INC. | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2013 |
| BIOGEN INC. | Corporate Officer/Principal | 01.04.2011 |
Roche Pharmaceuticals, Inc.
 Roche Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Provides research and development services | Corporate Officer/Principal | 01.08.2007 |
Pharmacia Corp.
 Pharmacia Corp. Pharmaceuticals: MajorHealth Technology Researches, manufactures and sells pharmaceuticals | Corporate Officer/Principal | 01.01.2002 |
| MOMENTA PHARMACEUTICALS, INC. | Technik-/Wissenschafts-/F&E-Leiter | - |
Ausbildung von Anthony Manning
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
87
Beziehungen ersten Grades
11
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 11 |
|---|---|
Celgene Corp.
 Celgene Corp. BiotechnologyHealth Technology Develops cancer and immunology drugs | Health Technology |
Biogen, Inc.
 Biogen, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets therapies for neurological and neurodegenerative diseases | Health Technology |
Palatin Technologies, Inc.
 Palatin Technologies, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops medicines based on molecules for the modulation of melanocortin receptor system | Health Technology |
Signal Pharmaceuticals, Inc.
 Signal Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Provides biopharmaceutical research focused on the discover of new drugs | Commercial Services |
Roche Pharmaceuticals, Inc.
Roche Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Provides research and development services | Commercial Services |
Momenta Pharmaceuticals, Inc.
 Momenta Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company that discovers and develops novel biologic therapies for the treatment of rare immune-mediated diseases | Health Technology |
Rein Therapeutics, Inc.
 Rein Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops stapled peptide drugs | Health Technology |
University of Otago
 University of Otago Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Pharmacia Corp.
Pharmacia Corp. Pharmaceuticals: MajorHealth Technology Researches, manufactures and sells pharmaceuticals | Health Technology |
Institute For Biomedical Entrepreneurship, Inc. | |
Monte Rosa Therapeutics, Inc.
 Monte Rosa Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company that develops molecular glue degrader medicines for oncology, autoimmune and inflammatory diseases | Health Technology |
Wählen Sie MarketScreener 
